Skip to main content
. Author manuscript; available in PMC: 2017 Nov 20.
Published in final edited form as: Diabetes Res (Fairfax). 2015 Aug 21;1(4):84–91. doi: 10.17140/DROJ-1-115

Figure 4.

Figure 4

Apelin gene therapy on NF-kb and HIF-1α expression. (A) Ad-apelin treatment significantly reduced NFkb expression in WT-STZ post-MI mice in comparison with Ad-β-gal injection. Apelin gene therapy had little effects on the NFkb expression in Sirt3 KO-STZ mice. (B and C) Ad-apelin treatment did not alter HIF-1α and PHD2 levels in WT-STZ and Sirt3 KO-STZ post-MI mice in comparison with Ad-β-gal injection.